here is evidence to suggest that fractures heal more rapidly in patients with a head injury as a result of systemic factors released from the site of this injury. We have measured the circulating level of insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in serum because of their known involvement in the stimulation of the activity of osteoblasts and the healing of fractures.
The healing of fractures of the long bones involves a complex series of cellular and biochemical events which are thought to arise primarily from the response of periosteal cells to disruption of the mechanical integrity of bone. 1 There have been several reports that both the production of callus and the rate of healing of fractures are increased by concomitant head injury. 2-4 Spencer 3 compared fractures of the long bones at different sites in surviving adults with severe head injury with those in an age-and gender-matched control group without head injury. The greatest healing response was found in the patients with the most severe head injury and this directly correlated with an accelerated time of union of the fracture.
Perkins and Skirving 2 compared two groups of patients with and without head injury, in whom fractures of the femoral shaft had been fixed by intermedullary nailing. The callus was significantly greater in the group with head injury and the mean time to radiological union was reduced.
The phenomenon of the altered healing of fractures in patients with head injury is also supported by the histological observations of the formation of ectopic bone 3 and by heterotopic ossification in patients with traumatic paraplegia. 5 Although healing of the fracture and the formation of bone in ectopic sites may differ clinically, both depend on the activity of osteogenic cells. The release of a circulating osteogenic factor from the site of the head injury is a possible explanation for the connection between CNS injury and the formation of new bone at a distant location. Studies in vitro showing that both the proliferation of osteoblasts and the production of alkaline phosphatase are stimulated by serum from patients with head injury [6] [7] [8] have provided evidence for this hypothesis. Other possible factors affecting the repair of fractures after head injury include altered neuronal activity and drug intervention. Insulin-like growth factor-1 (IGF-1) is able to influence cells involved in the healing of fractures such as chondrocytes 9 and osteoblasts, 10 and can also stimulate the synthesis of collagen in bone. 10, 11 In healthy individuals, serum levels of IGF-1 peak at puberty and decline with age. 12,13 IGF-1 is bound to a family of insulin-like growthfactor-binding proteins (IGFBPs) 12 which enhance or inhibit the proliferative and mitogenic effects of IGF-1 depending on the particular IGFBP, the cell type and the physiological milieu. 14, 15 The action of the IGFBPs is partially dependent on the activity of protease [16] [17] [18] [19] and the resulting fragments have reduced affinity for IGFs. 20 Dissociation of IGF from the binding complex allows free IGF to assume biological activity, 21 but recent reports have described IGF-independent bioactivity of some IGFBP-3 fragments. 19, 22 We chose to measure the circulating levels of IGF-1 and IGFBP-3 because they are thought to provide a good measure of the overall release and activity of growth hormone (GH) 23, 24 which acts on osteoblasts and influences turnover of bone. 25, 26 The release of GH from the anterior pituitary is pulsatile and measurement of its production requires frequent sampling. 27 Detailed measurement of the production of GH in patients with head injuries not directly involving the hypothalamic/pituitary axis has not been published, but there is evidence of both increased baseline secretion and of a loss of responsiveness to homeostatic control mechanisms. 28, 29 Patients and Methods
We selected patients using the following exclusion criteria: patients younger than 18 years or over the age of 75 years, diabetics, those on steroids or bisphosphonates and those with a previous head injury or bone-related problem. Table  I gives the details of the patients in the study. The Glasgow coma scale (GCS) 30 and injury severity score (ISS) 31 were calculated for each patient on arrival and at intubation as part of the assessment of the patient. The GCS is used to assess the level of consciousness in patients with head injuries using three subscales: eye opening, verbal response and motor response. The scores range from 3 to 15 in which 15 indicates a fully alert, orientated person and 3 is indicative of a deep coma. The ISS is used to grade all injuries. The body is divided into seven regions and a severity code is used to describe individual injuries in six categories. The highest ISS score obtainable is 75. Ethical approval was obtained from the local research Ethics Committee and, following written consent from the patient or next of kin, 20 ml blood were obtained from eight patients with head injury and fracture (5 male, 3 female), five with head injury only (4 male, 1 female) and three with fracture only (2 male, 1 female) within the first few hours of admission to hospital. Weekly samples were obtained from patients with head injury for the duration of their stay in hospital. Initial data points were available for all subjects and univariate analysis of variance with age and gender as covariants was performed on these data to assess the differences between groups. Blood was taken from 13 age-and gender-matched patients (9 male, 4 female) attending outpatient appointments and additionally from ten apparently healthy volunteers (4 male, 6 female). All blood samples were allowed to clot for 30 minutes at room temperature and spun at 3000 rpm for ten minutes. Serum was removed and stored at -70°C until use.
Serum was thawed at room temperature and mixed well before use. The serum levels of IGF-1 and IGFBP-3 were measured by enzyme-linked immunosorbant assay (ELISA) (Diagnostic Systems Laboratories Inc, Webster, Texas) following the manufacturer's instructions. Two methods were used for the measurement of IGF-1. Both used sandwichtype immunoassay and in one an additional dissociation step was included which had been optimised to separate IGF from the IGFBPs. The IGFBP-3 ELISA detects both fragments of IGFBP-3 and intact IGFBP-3. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were performed to determine if the IGFBP-3 detected was mostly intact or fragmented. 32 The initial serum samples from patients with head injury and fracture were compared with those of healthy volunteers by protein separation on a 10% SDS polyacrylamide non-reducing gel. The proteins were transferred on to nitrocellulose membrane (Sigma) by electroblotting and nonspecific sites blocked overnight with 1% bovine serum albumin (Sigma). Primary antibody (Diagnostic Systems Laboratories Inc) was applied at 1/1000 for four hours, membrane washed, and alkaline-phosphatase-labelled rabbit anti-goat IgG (Vector Laboratories Inc, California) at 1/1000 applied. The membrane was developed with 5-bromo-4-chloro-3-indolyl phosphate nitroblue tetrazolium substrate (Vector Laboratories) and air dried. Statistical analysis. This was performed using SPSS for Windows Version 9.0 (SPSS Inc, Chicago, Illinois). Blood samples were obtained from patients on a weekly basis limited by their duration of stay in hospital. The level of IGF-1 and IGFBP-3 is affected by age and gender and therefore univariate analysis of variance was performed with age and gender as covariants thus controlling for these factors in the model. All groups were compared with the volunteers. Additionally, the group of apparently healthy individuals provided weekly blood samples to determine week-to-week variations in IGF-1 and IGFBP-3. correlation of the two methods, further measurements of IGF-1 were performed using the extraction method. Age and gender had a significant effect on IGF-1 but less on IGFBP-3 (Table II) . With increasing age, the level of IGF-1 decreased and this remained significant when comparing both the initial time points and the mean value. The data also show that males had a significantly higher circulating level of IGF-1 irrespective of the study group.
The circulating level of both IGF-1 and IGFBP-3 was significantly lower in patients with both head injury and fracture at the initial time point corrected for age and gender and this remained significant when all time points were considered (Table II and Fig. 1 ). The level of IGF-1 and IGFBP-3 in patients with head injury was also lower than those of the control group, although only the data obtained from the initial time point for IGF-1 were significant (Table II) . When comparing patients with head injury with and without fracture with their age-and gendermatched controls, the Wilcoxon signed-rank test gave an exact two-tailed p value for IGF-1 of 0.02 and for IGFBP-3 of 0.03.
The level of IGF-1 and IGFBP-3 were measured in apparently healthy volunteers weekly. Fluctuation in the circulating level of both IGF-1 and IGFBP-3 was found, but neither showed a consistent trend.
No significant differences were found between IGF-1 samples obtained from age-and gender-matched patients attending outpatient phlebotomy clinics and the volunteers at either the initial time point or when the mean values were considered.
Western blotting revealed a protein of approximately 45kD and two smaller proteins of approximately 34kD and 35kD. No other fragments were observed. There were no differences in the pattern of fragments found in serum obtained from patients with head injury and fracture compared with that of the volunteers.
Discussion
The results show that the circulating level of IGF-1 is significantly lower in patients with head injury and fracture and head injury only compared with that in apparently healthy individuals.
It has been shown in both rats and obese males that nutritional status influences the serum concentration of IGF-1 33, 34 and it has been postulated that alteration in the nutritional status is a potent regulator of this. Van de Berghe, de Zegher and Lauwers Veldhuis 35 suggested that in critically ill patients, although not with head injury, the serum IGF-1 level correlated well with conventional nutritional indices, such as nitrogen balance. Similarly, Ross, Miell and Freeman 36 reported that the level of IGF-1 was lower in critically ill patients compared with a control group, but their study suggested that this was not altered by nutritional status. They hypothesised that there is an adaptive change in critically ill patients away from the indirect effects of GH (stimulation of IGF-1 production and anabolism) and towards the direct effects (lipolysis and insulin antagonism) which increases the availability of energy substrates. They studied critically ill patients requiring major abdominal surgery and excluded patients with head injury. It is possible, however, that a similar response occurs in patients with head injury and this cannot be discarded as a possible explanation for the results presented in our study.
Of our 13 patients with head injury, ten received intravenous dopamine in varying doses (2.7 to 9.5 g/kg/min) and for a variety of days, but in none did this exceed seven. Dopamine has been shown to affect the level of IGF-1 in critically ill patients 35, 37, 38 although none of the reports involved patients with head injury. Particularly, Van de Berghe et al 35 showed that prolonged infusion of dopamine for 83 to 296 hours was associated with a low concentration of IGF-1 compared with no dopamine or only a brief infusion for 15 to 21 hours. Although the data presented in our study show that IGF-1 was suppressed in patients with head injury compared with healthy volunteers, it is unlikely to be a result of the infusion of dopamine. The initial blood sample was taken within hours of the admission of the patient and before receiving drugs such as dopamine.
Our results show that males have a significantly higher level of circulating IGF-1 than females at initial time points and that this significantly decreases with age irrespective of gender. This significance remained when data from all time points were considered. Yu, Mistry and Nicar 39 showed that the level of IGF-1 was slightly higher in females than in males. Their data were obtained from pooled samples of serum and EDTA plasma and therefore cannot be directly compared with our data which were obtained from serum samples. Our findings reflect previous reports that the level of IGF-1 decreases with age. [40] [41] [42] The circulating level of IGFBP-3 was significantly lower in patients with head injury and fracture compared with that in volunteers at the initial time point and this remained significant when all time points were considered. None of the other groups showed significantly different values when compared with volunteers.
In order to determine whether the level of IGF-1 and IGFBP-3 fluctuated on a weekly basis repeated samples were taken from seven volunteers, in four for three weeks and in three for two weeks. The circulating level of both IGF-1 and IGFBP-3 varied widely and without any trend, indicating that the level of these analytes in blood does not remain constant. Stratakis, Mastorakos and Magiakou 43 measured the level of IGF-1 and IGF-2 in young adults of normal and tall stature and found that they had large circadian variation with a nocturnal surge, when measured in "acid-ethanol extracted" plasma. They found that measurements of IGF-1 in "unextracted" samples failed to reveal the same circadian variation in any of the subjects studied. The weekly variation in the circulating levels of IGF-1 and IGFBP-3 in the healthy volunteers in our study is unlikely to be explained by circadian variation because each sample was obtained within a 90-minute period around midday.
Western blotting revealed three proteins of different weights in serum obtained from apparently healthy volunteers and patients with head injury and fracture. The largest of these was approximately 45kD. Op De Beeck et al 44 assessed the pattern of IGFBP-3 fragments in normal human serum using Western blotting and enhanced chemiluminescence. In our study, proteins of similar sizes, also observed by Op De Beeck et al, 44 were found and there were no differences between patients with head injury and fracture compared with control subjects. The largest protein is likely to be the glycosylated protein since its reported size is approximately 44 to 48kD while the smaller proteins are likely to be the non-glycosylated proteins. 45 Our study has shown that the circulating level of IGF-1 is significantly lower in patients with head injury and fracture and head injury only, and is significantly higher in males than in females. In addition, the level of IGFBP-3 is significantly lower in patients with head injury and fracture compared with healthy individuals and the circulating level of IGF-1 and IGFBP-3 in healthy volunteers varied from week to week. These results suggest that IGF-1 and IGFBP-3 are not the circulating factors responsible for the altered fracture healing, but this does not eliminate a role for IGF-1 and IGFBP-3 at the tissue level. Andrew et al 46 reported osteoblastic and non-hypertrophic chondrocytic expression of mRNA for IGF-1 at the stage of formation of both bone and cartilage in the normal healing of fractures in man. If the secretion of GH is increased in patients with head injury it may be acting to increase IGF-1 locally at the site of the fracture. The current results, however, showing a decrease in the release of IGF-1 into the circulation may indicate a lack of responsiveness of GH. It is clear that the search for a circulating factor responsible for the altered healing of fractures seen after head injury continues.
